Loss of TSC gene function activates the mammalian target of rapamycin (mTOR) signaling pathway, which is a key regulator of cell growth, motility, and survival, resulting in the proliferation of LAM cells [14]. The gene discussed is MTOR; the disease is lymphangioleiomyomatosis.